109 related articles for article (PubMed ID: 1061042)
1. Extremity perfusion chemotherapy. Past, present and future.
Serrou B; Romieu C
Panminerva Med; 1976; 18(1-2):14-7. PubMed ID: 1061042
[No Abstract] [Full Text] [Related]
2. Hyperthermia and chemotherapy by regional perfusion for tumors of the extremities.
Cavaliere R; Di Filippo F; Moricca G; Santori F; Varanese A; Cavallari A; Carlini S; Brunori M; Aloe L; Monticelli G
Prog Clin Biol Res; 1982; 107():775-92. PubMed ID: 6962956
[No Abstract] [Full Text] [Related]
3. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy].
Kolessov VI; Levin AO
Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391
[No Abstract] [Full Text] [Related]
4. [Dye concentration measurements for the determination of leakage during and following normothermic cytostatic perfusion in the treatment of tumors of the extremities].
Krauss J; Lange U; Pauer HD; Krauss I
Z Exp Chir Transplant Kunstliche Organe; 1984; 17(5):269-74. PubMed ID: 6095550
[TBL] [Abstract][Full Text] [Related]
5. [Regional perfusion therapy of malignant tumors of the extremities].
Boeckl O; Hell E; Zimmermann G
Dtsch Med Wochenschr; 1970 Mar; 95(13):707-10. PubMed ID: 4985407
[No Abstract] [Full Text] [Related]
6. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
Hafström L
Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
[No Abstract] [Full Text] [Related]
7. Isolated limb perfusion: past experience and present studies using a minimal-access approach.
Rosin DR
Melanoma Res; 1994 Mar; 4 Suppl 1():51-5. PubMed ID: 8038598
[No Abstract] [Full Text] [Related]
8. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
[TBL] [Abstract][Full Text] [Related]
9. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
Ghussen F; Groth W; Nagel K
Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
[TBL] [Abstract][Full Text] [Related]
10. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.
Kroon BB
Eur J Surg Oncol; 1988 Apr; 14(2):101-10. PubMed ID: 3360151
[No Abstract] [Full Text] [Related]
11. Isolation limb perfusion for melanoma: current trends and future directions.
Coit DG
Melanoma Res; 1994 Mar; 4 Suppl 1():57-60. PubMed ID: 8038599
[TBL] [Abstract][Full Text] [Related]
12. [Regional hyperthermic perfusion--therapeutic concept and long term results].
Göhl J; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1992; ():494-501. PubMed ID: 1493314
[TBL] [Abstract][Full Text] [Related]
13. [Regional perfusion with nitrogen mustard in the treatment of malignant tumors of the lower extremities].
Jelicić I; Pasini M; Prpić I; Relja-Vladović T; Hancević J
Lijec Vjesn; 1969; 91(12):1283-92. PubMed ID: 5269977
[No Abstract] [Full Text] [Related]
14. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma and isolated limb perfusion.
Giraud RM
S Afr J Surg; 1984; 22(4):243-8. PubMed ID: 6523302
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma.
Kam PC; Thompson JF
Surg Oncol Clin N Am; 2008 Oct; 17(4):795-804, ix. PubMed ID: 18722919
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of malignant melanomas with perfusion in extracorporeal circulation].
Roselló Ochoa E
Actas Dermosifiliogr; 1970; 61(11):397-9. PubMed ID: 5526740
[No Abstract] [Full Text] [Related]
18. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
Kroon BB; Schraffordt Koops H
Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
[TBL] [Abstract][Full Text] [Related]
19. Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma?
Garrido-Laguna I; Ponz M; Espinós J
J Clin Oncol; 2007 Mar; 25(9):1149; author reply 1149-51. PubMed ID: 17369585
[No Abstract] [Full Text] [Related]
20. [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion].
Kroon HM; Thompson JF; Hoekstra HJ
Ned Tijdschr Geneeskd; 2009 Mar; 153(11):508-14. PubMed ID: 19402327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
